|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 319.70 DKK | -1.45% |
|
-0.44% | -1.71% |
| 07-14 | CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance | RE |
| 07-14 | Where would AI lead Pharma in the long run? |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 316.91 | -2.31% | 24 | ||||||
| 1,251.04 | +5.85% | 28 | ||||||
| 262.27 | +1.75% | 22 | ||||||
| 265.5 | +7.06% | 28 | ||||||
| 359.22 | +8.62% | 18 | ||||||
| 153.66 | +0.2% | 21 | ||||||
| 212.91 | +26.2% | 22 | ||||||
| 356.62 | -1.06% | 29 | ||||||
| 158.3 | +20.47% | 27 | ||||||
| 28.79 | +17.59% | 26 | ||||||
| 556.96 | +15.97% | 25 | ||||||
| 62.96 | +6.1% | 24 | ||||||
| 21.2 | +8.53% | 19 | ||||||
| 96.31 | +24.92% | 23 | ||||||
| 10,006.67 | +38.4% | 15 | ||||||
| 54.03 | +8.23% | 17 | ||||||
| 80.92 | +45.15% | 15 | ||||||
| 6,106.87 | +14.83% | 15 | ||||||
| 4.142 | +13.49% | 17 | ||||||
| 437.42 | +51.85% | 24 | ||||||
| Average | 1,039.63 | +15.59% | 22 | ||||||
| Weighted average by Cap. | 704.02 | +9.05% | 24 |
- Stock Market
- Stocks
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition